| scholarly article | Q13442814 |
| P50 | author | Diana Golden | Q80564349 |
| P2093 | author name string | Elizabeth A Saria | |
| Marc F Hansen | |||
| P2860 | cites work | The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis | Q24297505 |
| Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis | Q24324701 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer | Q27657185 | ||
| Cell migration: integrating signals from front to back | Q27860670 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| RANK-L and RANK: T cells, bone loss, and mammalian evolution | Q28203468 | ||
| RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 | ||
| Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases | Q29614338 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Akt1 in osteoblasts and osteoclasts controls bone remodeling | Q33303666 | ||
| Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling | Q34049570 | ||
| Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands | Q34225114 | ||
| Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology | Q34325803 | ||
| Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. | Q35848843 | ||
| Acute mitochondrial inhibition by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) 1/2 inhibitors regulates proliferation | Q36579425 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| Off-target effects of MEK inhibitors | Q37385007 | ||
| The EGFR network in bone biology and pathology | Q37612566 | ||
| Emerging MEK inhibitors. | Q37691441 | ||
| Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors. | Q39495372 | ||
| Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration | Q39699552 | ||
| In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. | Q39830937 | ||
| Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas | Q39849289 | ||
| Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells | Q39982164 | ||
| Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis | Q40038407 | ||
| RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes | Q40050213 | ||
| IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. | Q40056672 | ||
| Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells | Q40081669 | ||
| Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. | Q40166492 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. | Q40560452 | ||
| p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades | Q40660690 | ||
| U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. | Q40703359 | ||
| ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase | Q40744542 | ||
| Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors | Q40868033 | ||
| Development and characterization of a conditionally immortalized human fetal osteoblastic cell line | Q41376369 | ||
| Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis | Q41958166 | ||
| Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts | Q42507953 | ||
| Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase | Q42631549 | ||
| Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation | Q42803648 | ||
| Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling. | Q42809716 | ||
| Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts | Q44582479 | ||
| Differential regulation of platelet-derived growth factor stimulated migration and proliferation in osteoblastic cells | Q45231176 | ||
| Chemotaxis of human articular chondrocytes and mesenchymal stem cells | Q47722749 | ||
| IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. | Q53621706 | ||
| RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells. | Q54681646 | ||
| Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts | Q59261125 | ||
| P433 | issue | 12 | |
| P921 | main subject | osteoblast | Q917177 |
| P304 | page(s) | 2951-2960 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling | |
| P478 | volume | 230 |
| Q91829140 | A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas |
| Q64254224 | Autocrine production of reproductive axis neuropeptides affects proliferation of canine osteosarcoma in vitro |
| Q59000048 | Dynamic Tracking of Osteoblastic Cell Traction Force during Guided Migration |
| Q48162025 | Importance and regulation of adult stem cell migration |
| Q57170076 | Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy |
| Q46347453 | Osteoblast migration in vertebrate bone |
| Q26747442 | RANK-RANKL signalling in cancer |
| Q59806646 | RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation |
Search more.